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BARRÉ, HERVÉ, FRÉDÉRIQUE COHEN-ADAD, AND JEAN- 
LOUIS ROUANET. Two daily glucagon injections induce nonshiv- 
ering thermogenesis in Muscovy ducklings. Am. J. Physiol. 252 
(Endocrinol. Metab. 15): E616-E620, 1987.-In 6-wk-old 
chronically glucagon-treated (GT) ducklings, the calorigenic 
effect of intraperitoneal test injection of glucagon was measured 
at  25 and 4°C ambient temperature (Ta). At 25°C Ta, the 
increase in metabolic rate (MR) due to test injection of glucagon 
(360 pg/kg) reached 5.3 W/kg (i.e., 98% above the saline control 
value) in GT ducklings and only 1.7 W/kg (i.e., 29% above the 
control value) in control (TN) ducklings. After the injection, 
GT ducklings developed a hyperthermia, reaching 2.4"C, ac- 
companied by intense panting, whereas thermal body temper- 
ature did not change in TN ducklings. At 4°C Ta for the same 
dose of glucagon, no significant change in MR was observed in 
GT ducklings during 180 min of exposure, whereas a 25% 
decrease in MR occurred in the same conditions in TN duck- 
lings. In the cold, glucagon injection inhibited shivering in both 
groups of ducklings but thermogenesis was not suppressed in 
GT ducklings, showing a true nonshivering thermogenesis in 
these birds. This nonshivering thermogenesis was estimated to 
be 3 W/kg (i.e., 55% above resting MR). Such changes produced 
by chronic glucagon treatment resemble the artificial cold 
acclimation of rats chronically treated by norepinephrine. 
birds; acclimation to cold; calorigenic effect of glucagon; shiv- 
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NONSHIVERING THERMOGENESIS (NST) has long been 
considered as an exclusive attribute of mammals; birds 
resort only to shivering thermogenesis (14, 28, 30). In 
addition, birds are devoid of brown adipose tissue (2,21), 
the main site of NST in mammals. However, in cold 
acclimated young birds (ducklings) an important muscle 
thermogenesis coupled to  a reduced contractile activity 
has been observed (3). This potentiated shivering ther- 
mogenesis (PST) was accompanied by an increased sen- 
sitivity of muscle mitochondria to the uncoupling effect 
of free fatty acids (5) and in a later stage of cold accli- 
mation by the development of a true NST in response to 
cold (4). 
The role of glucagon in the control of heat production, 
particularly as a possible mediator of NST in birds, was 
first suggested by Freeman (12) on the grounds of the 
potent glycogenolytic and lipolytic action of this hor- 
mone, both in vivo and in vitro. A considerable increase 
in O2 consumption was later reported after glucagon 
injection in 3-mo-old Japanese quails (22), in winter- 
acclimatized king penguin chicks (6), and in 2- and 4- 
wk-old chicks (1) exposed to thermoneutral ambient 
temperature (Ta). In addition, an increase in plasma. 
glucagon level was found in ducklings acclimated to 4°C 
Ta for 3 wk (4). 
If glucagon is a potential mediator of NST in birds, 
chronic treatment with glucagon should mimic the state 
of cold adaptation, as does treatment with norepineph- 
rine, in rats (23). To solve this problem, we have tried to 
induce artificially cold acclimation by repeated daily 
injections of glucagon to ducklings maintained at  thermal 
neutrality for 6 wk. We are reporting on the calorigenic 
effect of glucagon in these birds and on a true NST due 
to glucagon. The experiments were conducted at  two Ta, 
one in (at 25°C Ta) and one below the thermoneutral 
zone (at 4°C Ta). 
MATERIALS AND METHODS 
Animals. Male muscovy ducklings (Anas barbariae, 
pedigree R 31, INRA, France) were obtained from a 
commercial stock breeder (Ets Grimaud). They had free 
access to water and a commercial mash (Sanders 5061). 
For chronic treatment, the following schedule was used: 
from the age of 1 wk the ducklings were caged for a 
period of 6 wk at 25°C Tain a constant photoperiod (816 
lighkdark) and treated either with-glucagon (GT; 360 pg/ 
kg ip twice daily at 8 A.M. and 6 P.M.) or with saline 
solution (controls, TN). Cold acclimated ducklings (CA) 
were reared at  4°C Ta from the age of 1 wk (3). A total 
of 48 ducklings weighing between 1.450 and 1.750 kg was 
used. 
Metabolic rate. Metabolic rate (MR) was measured by 
indirect calorimetry, We used an open-circuit system 
derived from that of Depocas et al. (11) and already used 
for measurement in ducklings (3). The duckling deprived 
of food in the night was positioned in a thermostatic 
chamber ventilated by a constant atmospheric airflow 
(air speed 0.05 m/s). Variable heat loss by conduction on 
the ground was reduced by a polystyrene bed. Airflow 
rates (10 l/min) were measured using a ,Tylan mass 
flowmeter model 261 (accuracy -I- 0.5% of full scale), and 
converted to  qtandard values (STPD). The fractional con- 
centrations of O2 were monitored using a Servomex OA 
184 paramagnetic gas analyzer with full-scale response 
to a change from 21 to 20%. CO2 concentrations were 
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scale response of this analyzer was to a change from O to 
2%. The Oz and COz analyzers were calibrated before 
and after each experiment with known mixtures of Oz 
(& 0.01%) and COz (& 0.02%). The rates of O2 consump- 
tion and COz production were calculated according to 
the equation of Depocas and Hart (10). The caloric 
equivalent for O2 was determined from the respiratory 
quotient using Lusk tables (25). 
Shivering. Shivering was measured as integrated elec- 
tromyogram (EMG) activity by the procedure described 
by Barré et al. (3). Briefly, the EMG signal that was 
received from two monopolar electrodes inserted into the 
muscle (the gastrocnemius in this study) 5 mm apart was 
monitored on an oscilloscope and recorded directly on 
one channel of a Racia pen polygraph (DUO 75). The 
EMG signal, rectified and integrated, was displayed on 
the other channel of the polygraph. This expression of 
the EMG activity as the mean rectified value was shown 
to  give the best correlation with the MR in the pigeon 
(18). Air (Ta) and cloacal ( T b )  temperatures were mea- 
sured using copper-constantan thermocouples connected 
to  a Chessell model 320 recording potentiometer (accu- 
racy & 0.2"C). 
Experimental procedure. After 4 wk of chronic treat- 
ment, the effects of a separate glucagon test injection 
(similar to the injections for chronic treatment) on MR, 
Tb, and EMG activity were studied at 25°C Ta in the 
thermoneutral zone and at 4°C Ta in the cold zone, zones 
previously determined in ducklings reared at  25°C Ta (3). 
All measurements of MR, T b ,  and EMG activity were 
taken in darkness during daytime (between 8 A.M. and 7 
P.M.). To obtain metabolic steady state and thermal 
equilibrium, the duckling was left sitting in the thermo- 
static chamber for an initial 120-min adjustment period 
before the experiment was begun. This initial period was 
considered to be long enough, because there was no 
noticeable change of T b  and MRs over 3-4 h under 
constant Ta conditions. At the end of the initial period 
the duckling was usually very quiet. MR, T b ,  and EMG 
activity were recorded during a 20-min control period 
and then for 240 min after the intraperitoneal glucagon 
injection. Control experiments were conducted with sa- 
line in place of glucagon. Test injections were made 
between midday and 2 P.M. via a polyethylene catheter, 
intraperitoneally implanted before the beginning of the 
experiment and fixed with adhesive tape. 
Drugs. Saline dilutions of glucagon (Nova Industrie 
Pharmaceutique, Paris) were prepared for each experi- 
ment less than 2 min before injection. Glucagon was 
dissolved to a concentration of 1 mg/ml for injections. 
The injection volume was 500 pl, and the dose used was 
360 pg/kg. Control saline injection volume was 500 p1. 
Plasma determinations. Blood samples were collected 
on ducklings after decapitation and immediately centri- 
fuged at 4°C after sampling. Plasma free fatty acids 
(FFA) and triglycerides were measured using the enzy- 
matic Nefa-C test, Wako, and Triglyceride G test, Wako, 
from Wako Chemicals (Osaka, Japan), respectively. Al- 
iquots of plasma were deproteinized in 7% perchloric 
acid for assays of glucose (GOD-perid enzymatic method, 
Boehringer) and glycerol concentrations (glycerol UV- 
method, Boehringer) from Boehringer-Mannheim 
(Mannheim, FRG). 
Units and terms. International units and the glossary 
of Bligh and Johnson (7) have been used throughout this 
paper. Values have been presented as means -C SE. 
Student's t test and F test were used for statistical 
calculations. 
RESULTS 
Effect of chronic treatment. To determine the effect of 
chronic treatment on their growth rate, ducklings were 
weighed every day. Growth curves of both GT and TN 
ducklings (Fig. 1) were similar from day 8 to 16. But 
from day 17, body mass of GT ducklings was less (P  < 
0.05) than that of TN ducklings, and the difference 
between both GT and T N  ducklings increased with in- 
creasing age. Growth rate of GT ducklings appeared to 
be slower with the establishment of a plateau from the 
age of 5 wk ( F  = 1.99, P < 0.05). If the treatment was 
pursued beyond 6 wk, some GT ducklings ceased to eat 
and finally died through hyperthermia after glucagon 
injection. 
As shown in Table 1, chronic treatment with glucagon 
does not change the level of MR at either 25 or 4°C Ta 
as compared with controls. This result is at variance with 
the increased basal metabolic rate and metabolic re- 
sponse to cold in CA ducklings at 25 and 4°C Ta, respec- 
tively. 
Effects of saline solution injection (Figs. 2 and 3). In 
GT ducklings receiving saline solution injection at 25 
and 4°C Ta, no significant change in MR (at 25°C Ta, F 
= 0.12; at 4°C Ta, F = 0.88; NS) integrated EMG activity 
(at 4°C Ta, F = 0.76; NS) or Tb (at 25°C Ta, F = 0.18; at  
4°C Ta F = 0.08; NS) was observed after the injection. 
Effect of glucagon test injection. The effects of this 
hormonal test injection were studied comparatively in 
GT and TN ducklings at two values of Ta purposely 
chosen above and under the lower critical temperature 
(LCT) previously determined (3), i.e., at 25°C Ta (ther- 
moneutral zone) (Fig. 2) and 4°C Ta (cold zone) (Fig. 3). 
Results of glucagon test injections were also given in CA 
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FIG. 1. Growth rate from glucagon-treated (GT) and control (TN) 
ducklings, both reared at 25°C ambient temperature (Ta). Values are 
means and bars are SE; n = 6 in each group. 
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TABLE 1. Metabolic rates of ducklings 
at thermoneutrality or i n  the cold 
MR Measured, W/kg 
Without test After glucagon 
injection test injection 
25'CT. 4"CT. 25"CT. 4 T T ,  
GT ducklings 5.5k0.3 8.0-CO.2 10.8+0.2* 8.4k0.2 
TN ducklings 5.5k0.2 7.9k0.6 7.2k0.2* 5.420.21 
CA ducklings 6.1-CO.3 8.7k0.4 8.7+0.4* 7.4k0.4 
Values are means k SE n = 6 in each group of ducklings. Metabolic 
rates were measured at  25 and 4°C ambient temperature (Ta) in 
glucagon-treated (GT) and control (TN) ducklings (reared at 25°C Ta) 
and in cold-acclimatized (CA) ducklings (reared at  4°C Ta). In GT 
ducklings, the measurements were made at  least 14 h after the last 
glucagon injection. .MR, metabolic rate. Comparisons are made between 
MR values measured without or with glucagon test injection, at the 
same Ta. * P < 0.001; t P < 0.01. 
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FIG. 2. Effects of glucagon test injection (360 pg/kg ip) on body 
temperature (Tb) and metabolic rate in glucagon-treated (GT; closed 
circles) and control (TN, open circles) ducklings exposed to neutral 
ambient temperature (25°C Ta). GT ducklings also received intraperi- 
toneal saline solution injection (closed triangles). In GT ducklings, all 
points of Tb from min 15 and of metabolic rate from min 5 are 
significantly greater (PTI, < 0.01 and PMR < 0.001, respectively) than 
control values. In TN ducklings, all points of metabolic rate between 
min 30 and 120 are significantly greater (P < 0.05) than control values. 
Values are means and burs are S E  n = 6 in each group. 
ducklings for comparison (Table 1). 
At 25°C Ta after the glucagon test injection in GT 
ducklings, there was a sudden increase in MR. Its max- 
imum value (10.8 0.2 W/kg, i.e., 98.5% above the saline 
control value) was reached 40 min after this injection. A 
plateau was maintained for the next 40 min, and then 
MR decreased progressively. In TN ducklings, the glu- 
cagon-induced change in MR followed the same pattern 
as in GT ducklings, but the maximum value (7.2 -I- 0.3 
W/kg) that was only 29% above the saline control value 
was significantly lower ( t  = 6.52; P < 0.001) than the 
maximum value in GT ducklings. In CA ducklings, the 
maximum value in MR (8.7 k 0.4 W/kg) due to glucagon 
injection represented an intermediate increase in MR of 
44% above the saline control value. 
At 25°C Ta in GT ducklings, when MR increased from 
min 5 ( F  = 44.1; P < 0.001), T b  increased significantly 
only from min 15 (F  = 4.7; P < 0.01) due to an active 
polypnea (breathing frequency: 230 -t- 10 breaths/min in 
GT ducklings vs. 30 f 2 breaths/min in TN ducklings) 
starting some minutes after glucagon injection. The glu- 
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FIG. 3. Effects of glucagon test injection (360 pg/kg ip) on body 
temperature (Tb), metabolic rate, and integrated electromyogram 
(EMG) activity in glucagon-treated (GT; closed circles) and control 
( T N  open circles) ducklings exposed to 4°C Ta. GT ducklings also 
received intraperitoneal saline solution injection (closed triangzes). 
Shivering activity was inhibited by glucagon in both GT and T N  
ducklings for 75 min after the intraperitoneal injection: in these duck- 
lings, all points of integrated EMG activity between min 5 and 140 and 
between min 5 and 80, respectively, are significantly lower (P < 0.05) 
than control values. But metabolic rate and T b  decrease only in TN 
ducklings after glucagon injection: all points of metabolic rate between 
min 5 and 80 and of T b  between min 30 and 160 are significantly lower 
than control values. 
cagon-induced increase in T b  reached 2.4"C from min 80 
to 200 (43.6 -I- 0.4"C in GT ducklings vs. 41.2 0.2"C in 
Tn ducklings). 
At  4°C Ta no significant change in MR was observed 
in GT ( F  = 1.6; NS) and CA ducklings ( F  = 0.3; NS) 
after glucagon injection during 180 min of exposure at 
4°C Ta, although within 1 min after injection shivering 
activity was completely suppressed. Shivering activity 
was absent for 75 f 15 min, and full recovery occurred 
10-20 min after the first signs of reappearance, while 
MR increased. In TN ducklings, inhibition of shivering 
activity followed the same pattern as in GT ducklings 
but was concomitant with a 25.5% decrease in MR from 
min  5 after glucagon injection (F  = 8.8; P < 0.05). When 
shivering reappeared, MR increased to its initial rate. 
At 4°C Ta, Tb was not affected by glucagon injection 
in GT ducklings ( F  = 0.6; NS). In TN ducklings, the T b  
decrease was 25°C in the 100 min after glucagon injec- 
tion (39.0 k 0.4"C in TN ducklings at min 100 vs. 41.5 
f 0.2"C before glucagon injection). With the reappear- 
ance of shivering and the increase of MR, Tb increased 
t o  its initial level. 
Plasma metabolites. Table 2 shows the plasma metab- 
olite concentrations in GT and TN ducklings exposed to 
25°C Ta, 14 h after the last glucagon injection. In both 
groups, no significant changes occurred in blood glucose 
and plasma triglyceride levels. But in GT ducklings, 
plasma FFA and glycerol levels were, respectively, 112 
and 250% above the levels of controls. 
Cold resistance was assessed by measuring the change 
in cloacal temperature during a 180-min exposure to 
-15°C (Fig. 4). Whereas CA ducklings were better able 
to maintain Tb (40.3"C) than TN ducklings, GT duck- 
NST INDUCED BY GLUCAGON IN DUCKLINGS E619 
TABLE 2. Plasma metabolites in control 
and chronically glucagon-treated ducklings 
TN Ducklings GT Ducklings 
Glucose, mM 13.02f0.42 14.17-CO.69 
FFA, mM 0.08-CO.01 0.17*0.01* 
Glycerol, mM 0.10~0.02 0.35-CO.lOt 
Triglycerides, mM 2.4W0.25 1.72f0.26 
Values are means f SE; n = 6 in each group of ducklings. Plasma 
concentrations were measured 14 h after the last glucagon injection. 
See Table 1 for abbreviations. * P < 0.001; t P < 0.05. 
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FIG. 4. Change of cloacal temperature (Tb) during 180-min exposure 
to cold (-15°C Ta) in cold-acclimated (CA; closed squares), glucagon- 
treated (GT; closed circles), and control (TN; open circles) ducklings. 
There was no significant decrease of T b  in CA ducklings (F  = 1.11). 
But decrease of T b  is significant from min 150 in both GT ( F  = 17.48, 
P c 0.001) and TN ducklings (F  = 4.20, P < 0.05). Values are means 
and bars are SE; n = 6 in each group. 
lings were not. Indeed, T b  of T N  and GT ducklings 
decreased significantly from min 150 to the end of the 
experiment, reaching 38.9 and 39.4"C, respectively. 
DISCUSSION 
Chronic treatment of ducklings. The dose of glucagon 
(360 pg/kg twice a day) was within the range of the doses 
used in rats (500 pg/kg twice a day) (31). Inasmuch as 
glucagon pool is about 10 times larger in birds (duck, 
goose) than in mammals (27) and plasma glucagon level 
is 90% higher in cold-acclimated ducklings than in con- 
trols (4), this dose, although it might not be regarded as 
physiological, was actually lower than that previously 
used in mammals (31). 
Calorigenic action of glucagon. The calorigenic action 
of glucagon is well documented in mammals, newborn 
rabbits (15), rats (9), and dogs (29), but is not found in 
mice and guinea pigs (22). In birds, a considerable calo- 
rigenic effect comparable with that elicited by norepi- 
nephrine in mammals was induced by glucagon in winter- 
acclimatized penguin chicks (6), cold-acclimated duck- 
lings (this study), 3-mo-old Japanese quail (22), and 2- 
and 4-wk-old chickens (1) exposed to neutral ambient 
temperature, but this action was not observed in 2-day- 
old chicks (26) nor in pigeons (19). Note that in any case, 
these calorigenic actions were much less than the calo- 
rigenic action observed in GT ducklings. 
NST in GT ducklings. The prominent result of the 
present study was the potent thermogenic action of glu- 
cagon resulting in hyperthermia and leading sometimes 
to the death of the GT ducklings. This effect was ob- 
served despite the absence of shivering at thermoneu- 
trality and even despite the suppression of shivering in 
the cold. As this inhibition of shivering produced a 2.5 
W/kg decrease in MR in TN ducklings only and no 
significant MR variation in GT and CA ducklings, the 
metabolic effect of exogenous hormone during a test 
injection substituted for part of the regulatory thermo- 
genesis at 4°C Ta, relieving the shivering thermogenesis 
in GT and CA ducklings, as previously described in 
winter-acclimatized king penguin chicks (6). Under these 
conditions, in GT ducklings glucagon was responsible for 
a true NST that may be estimated to  be 3 W/kg (i.e., 
55% above resting MR). As this calorigenic response was 
seen both in GT ducklings and, to a lesser extent, in CA 
ducklings, one is justified in considering it as an NST 
comparable with that described in cold-acclimated mam- 
mals receiving norepinephrine (review in Ref. 17). How- 
ever, the previous observation of an ability of ducklings 
to develop an NST of muscular origin after cold accli- 
mation (3) raised the question of the action mechanism 
of glucagon. 
Sensitization to glucagon by chronic treatment. Duck- 
lings injected for 6 wk with glucagon acquired from day 
23 (i.e., 2 wk after the beginning of the chronic treat- 
ment) an increased sensitivity to  the calorigenic action 
of this hormone. The response to test injection was even 
larger than that of cold-acclimated ducklings at  neutral 
ambient temperature (5.3 vs. 2.6 W/kg). The change in 
sensitivity to  glucagon by chronic treatment is compa- 
rable with that described by Leblanc and Pouliot (23) for 
norepinephrine in rats treated for 45 days with this 
hormone (300 pg.kg-'.day-l), the mediator of NST in 
mammals. The same order of MR increase above basal 
values was obtained with both hormones, glucagon, and 
norepinephrine, respectively, 29 and 26% in control 
ducklings and rats, 98 and 75% in GT ducklings and 
norepinephrine-treated rats, and only 44 and 49% in 
cold-acclimated ducklings and rats. Although the effector 
tissue responsible for thermogenesis is different in both 
animals, because brown adipose tissue is lacking in birds 
(2, 21), a comparable mechanism of sensitization by 
repeated injections may be inferred for the hormone 
action. 
Mechanism of the glucagon thermogenic effect. The 
powerful thermogenic response to glucagon exhibited by 
GT ducklings at  25°C Ta appears as the chief result. The 
intense panting and the stretched posture were signs of 
a struggle against the hyperthermia caused by this excess 
thermogenesis. In the cold, glucagon thermogenesis sim- 
ply replaced shivering. Indeed, suppression of shivering 
was also observed in control ducklings at 4°C Ta. A 
similar inhibition of shivering after single glucagon in- 
jection has already been noted in the pigeon (19) and in 
the king penguin chick (6). A central neuromodulator 
action of glucagon, independent of the peripheral ther- 
mogenic effect similar to that observed in the rat (20), 
may explain the inhibition. On the other hand, if gluca- 
gon treatment of ducklings results in an enhanced ther- 
mogenesis from muscular activity, like PST observed in 
cold-acclimated ducklings (3), all muscular activity be- 
comes a threat of hyperthermia and shivering should be 
strictly controlled or even suppressed. 
Whereas norepinephrine does not produce any in- 
crease in MR and is not lipolytic in cold-acclimated (8) 
or in winter-acclimatized birds (6), glucagon is a potent 
lipolytic hormone in birds (13). At rest, 14 h after the 
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last glucagon injection, the higher plasma FFA level in 
GT ducklings could be due either to decreased utilization 
or increased mobilization from adipose tissue. Because 
an increase in plasma glycerol level usually roughly re- 
flects the increase in the rate of lipolysis in adipose tissue 
(16), the higher blood glycerol concentration in GT duck- 
lings favors the interpretation that the rate of FFA 
production is increased in these GT birds, even in ab- 
sence of stimulation by exogenous glucagon. However, 
even after glucagon test injection, the increase in FFA 
blood level can provide the cells with more fuel available, 
but cannot trigger the utilization of this fuel. The rapid 
metabolic response to injected glucagon is to be ascribed 
to a direct effect at the cellular level in the thermogenic 
tissue. It must be pointed out that the sensitivity to the 
uncoupling effect of FFA on muscle mitochondria is 
increased in CA ducklings (5). A similar modification is 
presently under investigation in GT ducklings (H. Barré, 
G. Berne, P. Brebion, F. Cohen-Adad, and J. L. Rouanet, 
unpublished observations). 
It is possible to parallel the artificial cold acclimation 
obtained in rats by chronic norepinephrine treatment 
(23) and the sensitization to glucagon observed in GT 
ducklings. Indeed the same differences between CA and 
GT ducklings are observed as in CA and chronically 
norepinephrine-treated rats: increased tolerance to low 
ambient temperatures only in CA ducklings, but not in 
GT and TN ducklings, and increase in resting MR in CA 
animals, but no changes in chronically hormone-treated 
animals. On the other hand, it is now acknowledged that 
cold acclimation in rats is triggered by continuous nor- 
epinephrine secretion during prolonged exposure to cold 
(24). Similarly, an increased secretion of glucagon was 
shown in CA ducklings (4). Thus glucagon has to be 
considered among the mediators of cold acclimation in 
birds during the period of growth. 
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